These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6662903)

  • 1. Evaluation of lymphocyte electrophoresis in patients with urogenital cancers.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Oct; 50(5):766-8. PubMed ID: 6662903
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analysis on lymphocyte electrophoretic mobility pattern in urogenital cancer patients].
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Nakajima H; Matsumoto K
    Nihon Hinyokika Gakkai Zasshi; 1983 Oct; 74(10):1727-33. PubMed ID: 6676552
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunologic assessment of urogenital carcinoma].
    Chou YH; Huang CH; Chiang CP
    Taiwan Yi Xue Hui Za Zhi; 1983 Nov; 82(11):1163-9. PubMed ID: 6584541
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte stimulation in urologic cancer patients.
    Catalona WJ; Tarpley JL; Chretien PB; Castle JR
    J Urol; 1974 Sep; 112(3):373-7. PubMed ID: 4859402
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cellular immunology of malignancies of urogenital tract (author's transl)].
    Ikegami K
    Nihon Hinyokika Gakkai Zasshi; 1977 Sep; 68(9):832-5. PubMed ID: 303720
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the immunologic competence in patients with urogenital cancers. I. Evaluation of nonspecific cellular immunity by delayed cutaneous hypersensitivity test and lymphocytes blastoid formation (author's transl)].
    Ono H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1064-77. PubMed ID: 7198700
    [No Abstract]   [Full Text] [Related]  

  • 7. [Behavior of specific blood lymphocyte types in various stages of tumor propagation].
    Ruhl E; Camphausen G; Kurisummoottil C
    Blut; 1971 Oct; 23(4):216-22. PubMed ID: 5123214
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte-induced angiogenesis assay--in cutaneous malignancies and cutaneous and genital warts.
    Szmurło A; Grzesik W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):85-7. PubMed ID: 2466452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody induction of lymphocyte-mediated cytotoxicity against human transitional-cell carcinomas of the urinary tract.
    Hakala TR; Lange PH; Castro AE; Elliott AY; Fraley EE
    N Engl J Med; 1974 Sep; 291(13):637-41. PubMed ID: 4859212
    [No Abstract]   [Full Text] [Related]  

  • 11. Transitional cell and renal carcinoma: cell-mediated immunity as determined by the lymphocyte titration technique.
    Hakala TR
    Natl Cancer Inst Monogr; 1978 Dec; (49):151-2. PubMed ID: 571043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Persistence of herpes simplex virus and adenoviruses in lymphocytes of patients with urogenital tumors].
    Kulcsar G; Dan P; Nasz J; Csata S; L'vov ND; Barinskiĭ IF; Posevaia TA
    Vopr Virusol; 1990; 35(1):50-2. PubMed ID: 2163569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the immunologic competence in patients with urogenital cancers. II. The effect of abnormal serum proteins on nonspecific cellular immunity (author's transl)].
    Ono H
    Nihon Hinyokika Gakkai Zasshi; 1981 Aug; 72(8):1078-91. PubMed ID: 7198701
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative evaluation on nonspecific immunoparameters and CEA as a tumor marker in urogenital cancer patients.
    Nakagami Y; Minowa T; Tozuka K; Hiraoka Y; Chin H; Matsumoto K
    Nihon Ika Daigaku Zasshi; 1983 Apr; 50(2):292-4. PubMed ID: 6683278
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.
    Sakamoto S; Maeda H; Yamasaki K; Aikawa S; Hinuma Y
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1105-15. PubMed ID: 7200019
    [No Abstract]   [Full Text] [Related]  

  • 16. A plasma factor inhibiting lymphocyte reactivity in urologic cancer patients.
    McLaughlin AP; Brooks JD
    J Urol; 1974 Sep; 112(3):366-72. PubMed ID: 4546711
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the risk of de novo malignancy in kidney transplant recipients: role for monitoring of peripheral blood lymphocyte populations.
    Fernández-Ruiz M; López-Medrano F; Allende LM; Andrés A; Paz-Artal E; Aguado JM
    Transplantation; 2014 Sep; 98(5):e36-7. PubMed ID: 25171527
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination chemotherapy for genito-urinary malignancies. First report: estimation of lymphocytes blastoid transformation by whole blood culture (author's transl)].
    Asahi T
    Nihon Hinyokika Gakkai Zasshi; 1978 Feb; 69(2):204-9. PubMed ID: 566343
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies in urology.
    Moon TD; Vessella RL; Lange PH
    J Urol; 1983 Sep; 130(3):584-92. PubMed ID: 6350618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of lymphocytes from patients with cancer of the urinary bladder: detection by a 3-H-proline microcytotoxicity test.
    Bean MA; Pees H; FOGH JE; Grabstald H; Oettgen HF
    Int J Cancer; 1974 Aug; 14(2):186-97. PubMed ID: 4477555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.